If this is indeed the case and the MOG-induced EAE resembles human multiple sclerosis (MS) in pathogenesis, then the FcμR EM41-42QL mutant offers an intervention in individuals with MS, using gene editing that permits reliable introduction of point mutations in induced pluripotent human stem cells (35). The gene discussed is MOG; the disease is myeloid sarcoma.